Virtual reality for sickle cell pain in the emergency room
Part of Blood & lymphatic, Genetic & congenital, Pain clinical trials.
This trial tests whether using a virtual reality (VR) headset, along with your usual pain treatment, can help reduce pain during a sickle cell crisis. It is for adults with sickle cell disease who are in the emergency department and receiving IV opioids for a vaso-occlusive crisis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have sickle cell disease.
- You are currently in the emergency department because of a sudden, severe pain crisis (vaso-occlusive crisis).
- You are receiving IV pain medicine (opioids) for this crisis.
- You do not have a history of seizures or known intolerance to virtual reality, and you have no vision or hearing problems that would prevent you from using a VR headset.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using virtual reality (VR) can help reduce pain during a sickle cell crisis when you're receiving IV pain medicine in the infusion center. VR might distract you from the pain and make you more comfortable.
This trial tests whether a virtual reality (VR) experience can help reduce pain during a sickle cell “vaso-occlusive crisis,” which is an episode of sudden, severe pain. It’s offered alongside the care team’s usual pain management to see if VR makes pain feel better.
This study tests if using virtual reality (VR) can help children and teens with sickle cell disease feel better during a severe pain episode. You would use VR while in the hospital to see if it reduces your pain.
This study looks at what causes pain in people with sickle cell disease. They hope to learn more about pain patterns to better help patients manage it.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This trial tests whether numbing a specific area (regional anesthesia) can reduce inflammation and pain during a sickle cell pain crisis. It may offer a new way to manage severe pain without strong medications.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.